226 related articles for article (PubMed ID: 16194870)
21. Fibrillary deposits: amyloids and tactoids.
Looi LM
Malays J Pathol; 1995 Jun; 17(1):1-10. PubMed ID: 8906998
[TBL] [Abstract][Full Text] [Related]
22. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
[TBL] [Abstract][Full Text] [Related]
23. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
Westermark GT; Westermark P
FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
[TBL] [Abstract][Full Text] [Related]
24. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice.
Ganowiak K; Hultman P; Engström U; Gustavsson A; Westermark P
Biochem Biophys Res Commun; 1994 Feb; 199(1):306-12. PubMed ID: 8123028
[TBL] [Abstract][Full Text] [Related]
25. Homozygous serum amyloid P component-deficiency does not enhance regression of AA amyloid deposits.
Usui I; Kawano H; Ito S; Hamada Y; Ishihara T; Maeda S
Amyloid; 2001 Jun; 8(2):101-4. PubMed ID: 11409030
[TBL] [Abstract][Full Text] [Related]
26. Slaughtered aged cattle might be one dietary source exhibiting amyloid enhancing factor activity.
Yoshida T; Zhang P; Fu X; Higuchi K; Ikeda S
Amyloid; 2009 Mar; 16(1):25-31. PubMed ID: 19291511
[TBL] [Abstract][Full Text] [Related]
27. Mice lacking serum amyloid P component do not necessarily develop severe autoimmune disease.
Soma M; Tamaoki T; Kawano H; Ito S; Sakamoto M; Okada Y; Ozaki Y; Kanba S; Hamada Y; Ishihara T; Maeda S
Biochem Biophys Res Commun; 2001 Aug; 286(1):200-5. PubMed ID: 11485329
[TBL] [Abstract][Full Text] [Related]
28. Ultrastructural organization of hemodialysis-associated beta 2-microglobulin amyloid fibrils.
Inoue S; Kuroiwa M; Ohashi K; Hara M; Kisilevsky R
Kidney Int; 1997 Dec; 52(6):1543-9. PubMed ID: 9407499
[TBL] [Abstract][Full Text] [Related]
29. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
[TBL] [Abstract][Full Text] [Related]
30. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.
Li JP; Galvis ML; Gong F; Zhang X; Zcharia E; Metzger S; Vlodavsky I; Kisilevsky R; Lindahl U
Proc Natl Acad Sci U S A; 2005 May; 102(18):6473-7. PubMed ID: 15843464
[TBL] [Abstract][Full Text] [Related]
31. Ultrastructural immunohistochemical localization of polyclonal IgG, C3, and amyloid P component on the congo red-negative amyloid-like fibrils of fibrillary glomerulopathy.
Yang GC; Nieto R; Stachura I; Gallo GR
Am J Pathol; 1992 Aug; 141(2):409-19. PubMed ID: 1497092
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
Pepys MB
Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
[TBL] [Abstract][Full Text] [Related]
33. Cross-seeding and cross-competition in mouse apolipoprotein A-II amyloid fibrils and protein A amyloid fibrils.
Yan J; Fu X; Ge F; Zhang B; Yao J; Zhang H; Qian J; Tomozawa H; Naiki H; Sawashita J; Mori M; Higuchi K
Am J Pathol; 2007 Jul; 171(1):172-80. PubMed ID: 17591964
[TBL] [Abstract][Full Text] [Related]
34. Brefeldin A inhibits experimentally induced AA amyloidosis.
Stenstad T; Husby G
J Rheumatol; 1996 Jan; 23(1):93-100. PubMed ID: 8838515
[TBL] [Abstract][Full Text] [Related]
35. Histological study of experimental murine AA amyloidosis.
Kuroiwa M; Aoki K; Izumiyama N
J Electron Microsc (Tokyo); 2003; 52(4):407-13. PubMed ID: 14599103
[TBL] [Abstract][Full Text] [Related]
36. Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination?
Gillmore JD; Hutchinson WL; Herbert J; Bybee A; Mitchell DA; Hasserjian RP; Yamamura K; Suzuki M; Sabin CA; Pepys MB
Immunology; 2004 Jun; 112(2):255-64. PubMed ID: 15147569
[TBL] [Abstract][Full Text] [Related]
37. Induction of AApoAII amyloidosis by various heterogeneous amyloid fibrils.
Fu X; Korenaga T; Fu L; Xing Y; Guo Z; Matsushita T; Hosokawa M; Naiki H; Baba S; Kawata Y; Ikeda S; Ishihara T; Mori M; Higuchi K
FEBS Lett; 2004 Apr; 563(1-3):179-84. PubMed ID: 15063745
[TBL] [Abstract][Full Text] [Related]
38. Glycosaminoglycans are part of amyloid fibrils: ultrastructural evidence in avian AA amyloid stained with cuprolinic blue and labeled with immunogold.
Gruys E; Ultee A; Upragarin N
Amyloid; 2006 Mar; 13(1):13-9. PubMed ID: 16690495
[TBL] [Abstract][Full Text] [Related]
39. Kinetics of glycosaminoglycan deposition in splenic AA amyloidosis induced in mink.
Wien TN; Sørby R; Omtvedt LA; Landsverk T; Husby G
Scand J Immunol; 2004 Dec; 60(6):600-8. PubMed ID: 15584971
[TBL] [Abstract][Full Text] [Related]
40. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
Sørby R; Espenes A; Landsverk T; Westermark G
Amyloid; 2008 Mar; 15(1):20-8. PubMed ID: 18266118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
